Prognosis of “Masked” Hypertension and “White-Coat” Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring

Abstract

Conventional BP measurements may not identify some individuals at high or low risk, but these people may be identifiable by the use of ambulatory BP.

Short- and long-term risk of cardiovascular events in white-coat hypertension

“…When compared to normotension, some studies [9][10][11] reported a similar risk in WCH, whereas others [12][13][14][15] reported a higher risk. These studies [8][9][10][11][12][13][14][15] were heterogeneous regarding the method used to define WCH, the cutoff values employed, the endpoints included and the populations studied. Thus, other studies are needed to add further insight into the clinical relevance of WCH during longer observational periods.…”

“…[3][4][5][6][7][8][9][10][11][12][13][14][15] Some studies have evaluated the prognostic impact of WCH in the short term. [3][4][5][6][7] The aforesaid studies reported that cardiovascular risk was significantly lower in subjects with WCH than in those with sustained hypertension (SH), [3][4][5][6][7] and similar between WCH and normotension.…”

“…In this context, other studies [8][9][10][11][12][13][14][15] have been performed, reporting conflicting results. Some of these studies [8][9][10][11] reported a lower risk in WCH when compared to SH, whereas others [12][13][14][15] reported a similar risk.…”

“…Some of these studies [8][9][10][11] reported a lower risk in WCH when compared to SH, whereas others [12][13][14][15] reported a similar risk. When compared to normotension, some studies [9][10][11] reported a similar risk in WCH, whereas others [12][13][14][15] reported a higher risk. These studies [8][9][10][11][12][13][14][15] were heterogeneous regarding the method used to define WCH, the cutoff values employed, the endpoints included and the populations studied.…”

Contemporary Problems of Evaluation of Hypertension Treatment Efficacy: Masked Hypertension and White Coat Hypertension

“…Не вызывает сомнения самостоятельное значение СНЛ, которая может быть следствием не только «склонности» па-циента к скрытой АГ («фенотип»), но и недостаточно эффективной антигипертензивной терапии у больных со стабильной АГ. Поэтому справедливым представ-ляется мнение T. Ohkubo et al [33] о большей прогно-стической «надежности» выявления феноменов ГБХ и скрытой АГ именно у больных, уже находящихся на ан-тигипертензивной терапии, по сравнению с больными АГ, по тем или иным причинам не получающим лече- Терапия АГ: скрытая неэффективность лечения и «гипертония белого халата» ния. Действительно, в случае СНЛ речь идет о несо-стоятельности избранной на достаточно длительный пе-риод тактики ведения пациента.…”